Matches 1 - 43 out of 43
Match Document Document Title
7276250 Sustained release formulations of oxymorphone  
Sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of oxymorphone or pharmaceutically acceptable salts...
7229642 Amino acid modulated extended release dosage form  
Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an...
7214387 Sustained release formulations of metformin  
The invention provides sustained release formulations of metformin or a pharmaceutically acceptable salt thereof, and methods of treating diabetes by administering to a patient a therapeutically...
7172766 Controlled release insufflation carrier for medicaments  
Controlled release powder insufflation formulations are disclosed. The powder formulation includes cohesive composites of particles containing a medicament and a controlled release carrier which...
EP1712230A1 PHARMACEUTICAL COMPOSITION FOR XEROPHTHALMIA AND XEROSTOMIA TREATMENT  
[Problem] An agent for treating eye and mouth dryness, which does not accompanies undesirable actions is provided. [Means for Resolution] Administration of the compound A made it possible to...
7056531 Sustained release compositions for orally administered substances and methods  
Sustained release composition for orally administered active substances that comprises maltodextrin and cellulose. This composition is suitable for forming tablets, gels when exposed to the fluids...
EP1152026B1 Polysaccharide material for direct compression  
Abstract of EP1152026 This invention relates to a method of using compressible polysaccharides having a tap density of less than 0.4 g/ml as a filler/binder for tablets prepared by direct...
6960356 Orally administered drug delivery system providing temporal and spatial control  
A pharmaceutical composition in the form of tablets or capsules provides a combination of temporal and spatial control of drug delivery to a patient for effective therapeutic results. The...
6936275 Amino acid modulated extended release dosage form  
Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an...
6875793 Once-a-day controlled release sulfonylurea formulation  
This invention is directed to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative...
6726930 Sustained release heterodisperse hydrogel systems for insoluble drugs  
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
6689386 Sustained release matrix for high-dose insoluble drugs  
Sustained release dosage forms of high dose insoluble drugs such as ibuprofen and methods for their manufacture are disclosed.
6572887 Polysaccharide material for direct compression  
This invention relates to a method of using compressible polysaccharides having a tap density of less than 0.4 g/ml as a filler/binder for tablets prepared by direct compression, excipient blends...
6537578 Once-a-day controlled release sulfonylurea formulation  
This invention is directed to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative...
6517868 Amino acid modulated extended release dosage form  
Disclosed herein is a tableted oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an...
6416786 Sustained release tablet containing hydrocolloid and cellulose ether  
The present invention is directed to a solid sustained release pharmaceutical tablet for administering to a host, comprising a therapeutically effective amount of a pharmaceutically active...
6387394 Controlled release insufflation carrier for medicaments  
Controlled release powder insufflation formulations are disclosed. The powder formulation includes cohesive composites of particles containing a medicament and a controlled release carrier which...
EP1152026A1 Polysaccharide material for direct compression  
This invention relates to a method of using compressible polysaccharides having a tap density of less than 0.4 g/ml as a filler/binder for tablets prepared by direct compression, excipient blends...
6261601 Orally administered controlled drug delivery system providing temporal and spatial control  
A pharmaceutical composition in the form of tablets or capsules provides a combination of temporal and spatial control of drug delivery to a patient for effective therapeutic results. The...
6245356 Sustained release heterodisperse hydrogel systems-amorphous drugs  
Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and...
6245355 Sustained release matrix for high-dose insoluble drugs  
Sustained release dosage forms of high dose insoluble drugs such as ibuprofen and methods for their manufacture are disclosed.
6197331 Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity  
The invention is directed to a controlled-release solid composition for the oral cavity or "pharmaceutical oral patch" that adheres to hard dental surfaces, such as teeth and dentures, and releases...
6136343 Sustained release heterodisperse hydrogel systems for insoluble drugs  
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
6093420 Sustained release matrix for high-dose insoluble drugs  
Sustained release dosage forms of high dose insoluble drugs such as ibuprofen and methods for their manufacture are disclosed.
6056977 Once-a-day controlled release sulfonylurea formulation  
This invention is directed to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative...
6048548 Sustained release heterodisperse hydrogel systems-amorphous drugs  
Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and...
6039980 Sustained release excipient  
A sustained-release formulation for use in oral solid dosage forms includes from about 10 to about 40 percent or more by weight galactomannan gum; from about 1 to about 20 percent by weight of an...
5962009 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Controlled release insufflation carrier for medicaments  
Controlled release powder insufflation formulations are disclosed. The powder formulation includes cohesive composites of particles containing a medicament and a controlled release carrier which...
5958456 Controlled release formulation (albuterol)  
A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient...
5846563 Sustained release heterodisperse hydrogel systems for insoluble drugs  
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
5738865 Controlled release insufflation carrier for medicaments  
Controlled release powder insufflation formulations are disclosed. The powder formulation includes cohesive composites of particles containing a medicament and a controlled release carrier which...
5667801 Sustained release heterodisperse hydrogel systems for insoluble drugs  
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
5662933 Controlled release formulation (albuterol)  
A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient...
5612053 Controlled release insufflation carrier for medicaments  
Controlled release powder insufflation formulations are disclosed. The powder formulation includes cohesive composites of particles containing a medicament and a controlled release carrier which...
5554387 Sustained release heterodisperse hydrogel systems for insoluble drugs  
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
5512297 Sustained release heterodisperse hydrogel systems for insoluble drugs  
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
5455046 Sustained release heterodisperse hydrogel systems for insoluble drugs  
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
5399362 Once-a-day metoprolol oral dosage form  
A sustained release oral solid dosage form of metoprolol pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, a cationic...
5399359 Controlled release oxybutynin formulations  
A solid oral sustained release oxybutynin formulation includes a sustained release matrix including a gelling agent, an inert pharmaceutical diluent, and a cationic cross-linking agent.
5399358 Sustained release formulations for 24 hour release of metroprolol  
A sustained release oral solid dosage form of metoprolol pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, a cationic...
5332727 Stable, ingestable and absorbable NADH and NADPH therapeutic compositions  
A stable, ingestable and intestine-absorbable therapeutic composition comprising NADH or NADPH, or physiologically acceptable salts thereof, in a pill form. The pill has an outer surface covered by...
5330761 Bioadhesive tablet for non-systemic use products  
The present invention relates to a controlled release bioadhesive tablet which includes a locally active agent, a heterodisperse gum matrix, and a pharmaceutically acceptable diluent. In certain...
4760628 Drawing-in of heddles remote from a loom harness frame  
Methods and means for allowing heddles to be drawn-in with warp yarns away from a loom for subsequent loading into the loom. A heddle holder allows rows of drawn-in heddles to be carried to the...
Matches 1 - 43 out of 43